Your session is about to expire
← Back to Search
Diabetes Prevention Programs for Prediabetes (LEAP Trial)
LEAP Trial Summary
This trial will test whether a standard or very low-carbohydrate version of the Diabetes Prevention Program better improves outcomes like blood glucose control and body weight for patients with prediabetes.
LEAP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLEAP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LEAP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot read, write, or speak English.I have trouble chewing or swallowing.I am taking diabetes medication that is not metformin.I am taking warfarin.I have not been treated for an eating disorder or severe mental health issues like depression with thoughts of suicide, bipolar disorder, or schizophrenia.I am not using any anti-obesity drugs or participating in another weight loss program.I have a blood condition that affects my HbA1c levels.I am overweight according to my BMI.Your HbA1c level is between 5.7% and 6.4% when checked at the start of the study.I am taking a water pill (diuretic) equivalent to 20mg or more of furosemide.Your thyroid stimulating hormone levels are not within the normal range.I am willing to join group sessions.I am taking oral corticosteroids.Following a very low-carbohydrate (keto) diet.You follow a vegan or vegetarian diet.I have a history of diabetes (type 1 or type 2).Your triglyceride levels are 600 mg/dL or higher.I can do light activities like walking.I have had or plan to have weight loss surgery during the study.Your potassium levels are not normal.My kidney function is severely reduced.
- Group 1: Standard NDPP
- Group 2: Very low-carbohydrate diet (VLCD)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any criteria that would exclude me from partaking in this research?
"Interested individuals between the ages of 21 and 75 with pre-diabetic conditions are encouraged to apply for this research trial, which is currently enrolling approximately 300 participants."
Is this clinical trial currently open to new enrollees?
"According to clinicaltrials.gov, this medical experiment is actively searching for participants. The trial was initially advertised on March 20th 2022 and the details were most recently updated on July 3rd 2022."
How many people are taking part in this research project?
"Affirmative. Records on clinicaltrials.gov reveal that this research project, initially posted in March 2022 and most recently revised in July of the same year, is urgently seeking 300 volunteers from a single site."
Does this medical trial have any age restrictions?
"This medical trial is seeking out individuals between the ages of 21 and 75. In contrast, there are 15 trials for patients below 18 and 184 clinical studies that cater to adults over 65 years old."
Share this study with friends
Copy Link
Messenger